Stay updated on Idasanutlin Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.

Latest updates to the Idasanutlin Combo in AML: Clinical Trial page
- Check13 days agoChange DetectedDifference0.3%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check27 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.6%
- Check55 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check63 days agoChange DetectedDifference0.3%
- Check70 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Acute Myeloid Leukemia (AML), while adding a new version number and specific medical terms.SummaryDifference7%
Stay in the know with updates to Idasanutlin Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.